Thursday, 14th November Clinical Oncology Society of Australia Annual Scientific Meeting 2019

• Beyond Cabazitaxel: Late Line Treatments in Metastatic Castration Resistant Prostate Cancer (mCRPC): A Retrospective Multi-Centre Analysis - Grace Chazan
• Melanomas and stress patterns on the plantar surface of the foot - Yun Megan Foo
• Victorian oesophagogastric cancer-service redesign program – a state-wide approach to improving care - Melissa Shand
• Administration of immune checkpoint inhibitors at rural towns using the Teleoncology model of care - Evaluation of safety at a regional cancer centre - Sebastian Kang
• Factors affecting Radiotherapy Utilisation (RTU) in Geriatric Oncology in New South Wales - Gabriel Gabriel
• Prevalence of advance care directive documentation among older Australians with cancer: multi-centre audit study.   - Helena Rodi
• Colorectal cancer in older adults: frequency of major resection and surgical outcomes - Nathan Dunn
• Modelling the health outcomes of immuno-oncology therapies in cancer care in Australia - Elias Toomeh
• Factors influencing organisational readiness for implementation of the Australian Clinical Pathway for the Screening, Assessment and Management of Anxiety and Depression in Adult Cancer Patients. - Liesbeth Geerligs

• Experiences of genitourinary cancer nurses with scanxiety and tumour marker-related anxiety in people with cancer: results of a survey - Kim Tam Bui
• Use and Outcomes from Neoadjuvant chemotherapy in Borderline Resectable Pancreatic Ductal Adenocarcinoma in an Australasian Population - Belinda Lee
• Exploring the Survivorship Abyss: Qualitative insights from survivors of prostate cancer 15 years post-diagnosis - Ilona Juraskova
• Real-world survival of advanced melanoma patients treated with immunotherapy and targeted therapy - Dan McKavanagh
• Disparities starting adjuvant chemotherapy for locally advanced cervical cancer in the international, academic, randomised, phase 3 OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274) - Linda Mileshkin
• Does physical activity participation associate with the degree of chemotherapy-induced peripheral neuropathy after neurotoxic treatment? - David Mizrahi
• Toxicity of combination immunotherapy in the elderly - Prachi Bhave
• NEU-HORIZONS: The neuroprotection and therapeutic use of riluzole for the prevention of oxaliplatin-induced neuropathy- a randomised controlled trial - Terry Trinh
• Changes in cancer survivors’ symptoms, lifestyle, and quality of life over one year: longitudinal data from the Sydney Cancer Survivorship Centre (SCSC) clinic - Janette L Vardy

• Cancer epidemiology across age spectrums (incidence, prevalence, burden and issues of disease) - David Roder
• Beyond age and gender – what about race?  - Lisa Whop
• The emergence of youth cancer services as a unique model of care  - Michael Osborn
• Older cancer patients - the evolution of geriatric oncology AND palliative care  - Jane Phillips

10:20 AM Panel Discussion 

• Why should I bother? The clinical benefits of germline genetic testing for a cancer patient. - Nicola Poplawski
• I did it – now what? Benefits and limitations of NGS testing - Karin S Kassahn
• Closing the loop – managing the patient and the family - Debra Trott

12:10 PM Panel Discussion 

• Recent advances in psychosexual interventions for prostate cancer  - Amanda Hutchinson
• Management of supportive care issues associated with systemic treatment of prostate cancer  - Alexandre Chan
• Continence challenges faced by prostate cancer survivors. - Kerry Santoro
• Dealing with the aftermath – the role of the prostate cancer nurse in helping men deal with the challenges that follow prostate cancer treatment - Sally Sara

12:20 PM Questions 

• Risk-stratified melanoma prevention and screening - Anne E Cust
• Prostate Cancer Screening: Confusion, Controversy and Enlightenment - Michael O'Callaghan
• Cancer Screening – A policy perspective  - Sanchia Aranda
• Challenges in demonstrating the value of cancer screening - Jonathan Karnon

12:05 PM Panel Discussion 

We are our own worst enemies!

As health professionals, do we practice what we preach?

Our ability to lead healthy lives – Nik Zeps v Linda Mileshkin

Cancer screening – Dorothy Keefe v Jon Emery

Presenter: An intimate Q&A and performance with Kirk Pengilly